DERMJourney Medical Corporation
6.020USD+1.01%Mkt Cap: 166.17M USDP/E: Last update: 2026-05-26

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.…

Indicators:|

Key Statistics

Company
Market Cap166.17M USD
Enterprise Value169.24M USD
Revenue (TTM)64.68M USD
Gross Profit40.93M USD
Net Income (TTM)-11.43M USD
Revenue/Share2.520 USD
Last Price6.020 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees58
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-103.50
PEG
EV/EBITDA-83.74
EV/Revenue2.62
P/S2.64
P/B5.51
EPS (TTM)-0.37
EPS (Forward)-0.06
52W Range
4.31033% of range9.555
52W High9.555 USD
52W Low4.310 USD
Profitability
Gross Margin66.17%
Oper. Margin-9.35%
EBITDA Margin-3.13%
Profit Margin-18.48%
ROE-35.89%
ROA-12.08%
Growth
Revenue Growth21.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-12.44M USD
CapEx (TTM)
FCF Margin-5.10%
FCF Yield-1.99%
Net Debt-1.75M USD
Net Debt/EBITDA0.87
Balance Sheet
Debt/Equity0.80
Current Ratio1.72
Quick Ratio1.38
Book Value/Sh1.128 USD
Cash/Share0.9890 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)13.50 USD
Target Range12.00 USD16.00 USD
# Analysts4
Ownership
Shares Out.21.53M
Float14.83M
Insiders32.31%
Institutions55.68%
Short Interest
Short Ratio17.6d
Short % Float24.54%
Short % Out.13.44%
Shares Short3.67M
Short (prev mo.)3.46M
Technical
SMA 505.613 (+7.3%)
SMA 2007.246 (-16.9%)
Beta1.03
S&P 52W Chg28.31%
Avg Vol (30d)240.88K
Avg Vol (10d)372.59K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)